ArticleRevista de saude publica2018

Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation.

Marcelo Cristiano de Azevedo Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.